A New Weight-Loss Tool: Will the Ozempic 2.0 Pill Spark a Breakthrough?

A new weight-loss medication — the Ozempic 2.0 pill — may enter the market next year, Breaking News English reported. It is an oral version of the widely used Ozempic injection. The manufacturer, Novo Nordisk, stated that clinical trials showed the pill reduced a person’s body weight by an average of 10.5%.

The competing company Eli Lilly is also developing its own weight-loss pill. Both medications are currently awaiting approval from the U.S. FDA.

Experts say this innovation will be very convenient for people struggling with excess weight as well as those with type 2 diabetes. The current Ozempic is administered as a weekly injection and requires refrigeration.

The new pill will be easier to take daily, more accessible, and suitable for widespread use around the world. Analysts also suggest that it may be more affordable.